Leung et al., 2013 - Google Patents
Enhanced cellular uptake and gene delivery of glioblastoma with deferoxamine-coated nanoparticle/plasmid DNA/branched polyethylenimine compositesLeung et al., 2013
View PDF- Document ID
- 18011130113087307365
- Author
- Leung K
- Chak C
- Lee S
- Lai J
- Zhu X
- Wang Y
- Sham K
- Cheng C
- Publication year
- Publication venue
- Chemical Communications
External Links
Snippet
Ternary composite nanomaterials based on deferoxamine-coated superparamagnetic iron oxide nanoparticles (8–10 nm), circular plasmid DNA (∼ 4 kb) with fluorescent/luminescent reporter group, and branched polyethylenimine (25 kDa, PDI= 2.5) were prepared and …
- 229920002873 Polyethylenimine 0 title abstract description 45
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Leung et al. | Enhanced cellular uptake and gene delivery of glioblastoma with deferoxamine-coated nanoparticle/plasmid DNA/branched polyethylenimine composites | |
| Wan et al. | Self-assembled magnetic theranostic nanoparticles for highly sensitive MRI of minicircle DNA delivery | |
| Li et al. | Gold‐coated Fe3O4 nanoroses with five unique functions for cancer cell targeting, imaging, and therapy | |
| Hua et al. | Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy | |
| Yan et al. | Recent advances in multifunctional magnetic nanoparticles and applications to biomedical diagnosis and treatment | |
| Ebrahiminezhad et al. | Preparation of novel magnetic fluorescent nanoparticles using amino acids | |
| Lin et al. | A novel aptamer functionalized CuInS2 quantum dots probe for daunorubicin sensing and near infrared imaging of prostate cancer cells | |
| Na et al. | Versatile PEG-derivatized phosphine oxide ligands for water-dispersible metal oxide nanocrystals | |
| Magro et al. | Covalently bound DNA on naked iron oxide nanoparticles: Intelligent colloidal nano-vector for cell transfection | |
| Heidari Majd et al. | Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles | |
| Yang et al. | Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism | |
| Chen et al. | In situ growth of β-FeOOH nanorods on graphene oxide with ultra-high relaxivity for in vivo magnetic resonance imaging and cancer therapy | |
| Dumont et al. | Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors | |
| Mahajan et al. | Magnetic quantum dots in biotechnology–synthesis and applications | |
| Li et al. | Polyetherimide-grafted Fe3O4@ SiO2 nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging | |
| Aeineh et al. | Glutathione conjugated polyethylenimine on the surface of Fe3O4 magnetic nanoparticles as a theranostic agent for targeted and controlled curcumin delivery | |
| Chung et al. | Microwave-assisted synthesis of carbon dot–iron oxide nanoparticles for fluorescence imaging and therapy | |
| Sweeney et al. | Peptide-mediated targeting mesoporous silica nanoparticles: a novel tool for fighting bladder cancer | |
| Bhattarai et al. | N-hexanoyl chitosan stabilized magnetic nanoparticles: implication for cellular labeling and magnetic resonance imaging | |
| Koktysh et al. | Fluorescent magnetic hybrid nanoprobe for multimodal bioimaging | |
| Wu et al. | Remotely controlled drug release based on iron oxide nanoparticles for specific therapy of cancer | |
| Ou et al. | Fabrication and cyto-compatibility of Fe3O4/SiO2/graphene–CdTe QDs/CS nanocomposites for drug delivery | |
| Chen et al. | Assembly of Fe 3 O 4 nanoparticles on PEG-functionalized graphene oxide for efficient magnetic imaging and drug delivery | |
| Geinguenaud et al. | Electrostatic assembly of a DNA superparamagnetic nano-tool for simultaneous intracellular delivery and in situ monitoring | |
| He et al. | Dual-mode fluorescence and magnetic resonance imaging nanoprobe based on aromatic amphiphilic copolymer encapsulated CdSe@ CdS and Fe3O4 |